Solid-Phase Nucleic Acid Amplification Without Rapid Thermal Cycling

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current sequencing platforms require clonal amplification of initial template library molecules to create clusters, which is costly and prone to non-specific amplification artifacts, and existing thermal cycling methods are expensive and inefficient.

Innovation Solution

A novel solid-phase amplification method using chemical and thermal denaturant cycles, where template polynucleotides are annealed to immobilized primers at controlled temperatures, followed by chemical denaturation and primer extension, to generate complementary polynucleotides without the need for rapid thermal cycling.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If rapid thermal cycling is used for nucleic acid amplification, then amplification efficiency is improved, but instrumentation cost and complexity increase

Engineering Contradiction:
Improveamplification efficiencyVSAvoidinstrumentation cost
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent replaces the mechanical thermal cycling system with a chemical denaturation system. Instead of using expensive thermal cyclers to denature DNA through temperature changes, the invention uses chemical denaturants (such as formamide or urea) to achieve DNA strand separation at constant temperature, thereby eliminating the need for complex thermal cycling instrumentation while maintaining amplification efficiency

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The invention changes the physical parameter used for DNA denaturation from temperature (thermal cycling) to chemical composition (denaturant concentration). By using chemical denaturants at constant temperature, the system achieves the same DNA separation effect without requiring rapid temperature changes, thus reducing instrumentation complexity while preserving amplification productivity

Inventive Principle:
Principle #35Parameter changes

2Device complexity

If isothermal nucleic acid amplification is used, then instrumentation cost is reduced, but non-specific amplification artifacts increase

Engineering Contradiction:
Improveinstrumentation costVSAvoidamplification specificity
Core Design Contradiction:
Device complexityVSReliability

Solution Approach 1:

The patent introduces chemical denaturants as intermediary substances to mediate the DNA denaturation process at constant temperature. These denaturants specifically disrupt hydrogen bonding between DNA strands without causing non-specific amplification, thereby maintaining amplification specificity while enabling isothermal conditions that reduce instrumentation cost

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The invention implements periodic addition and removal of chemical denaturants in a controlled manner. By cycling the denaturant presence rather than maintaining constant isothermal conditions, the system achieves specific amplification while keeping instrumentation simple, as the periodic chemical action replaces the need for complex thermal control

Inventive Principle:
Principle #19Periodic action

3Measurement precision

If clonal amplification to create clusters is performed, then signal-to-noise ratio is improved, but amplification cost and time increase

Engineering Contradiction:
Improvesignal-to-noise ratioVSAvoidamplification time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The patent performs preliminary attachment of template molecules to the solid support surface before amplification begins. By pre-positioning templates on the surface and using surface-immobilized primers, the system creates localized amplification sites that immediately generate detectable signals without requiring extensive clonal expansion time, thus improving signal-to-noise ratio while reducing amplification time

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The invention segments the amplification process into surface-immobilized localized reactions rather than bulk solution amplification. Each template molecule on the surface undergoes independent amplification, creating discrete signal sources that improve measurement precision. This segmented approach reduces the time required compared to traditional clonal amplification methods

Inventive Principle:
Principle #1Segmentation

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method reduces the cost and complexity of amplification, enhances signal-to-noise ratio, and improves sequencing accuracy by minimizing non-specific amplification artifacts.

Implementation Method 1

contacting the complement template polynucleotide and the template polynucleotide with a chemical denaturant at a second temperature thereby separating the complement template polynucleotide from the template polynucleotide

Methodology Applied
Scientific EffectChemical denaturation:

Implementation Method 2

wherein the second temperature is greater than the first temperature by 12° C. to 18° C.

Methodology Applied
Scientific EffectThermal denaturation:

Implementation Method 3

extending the first primer with a polymerase to generate a complement template polynucleotide

Methodology Applied
Scientific EffectPrimer extension: Enzyme

Implementation Method 4

annealing a template polynucleotide to a first immobilized primer on a solid support at a first temperature, wherein the first temperature is about 25° C. to about 45° C.

Methodology Applied
Scientific EffectAnnealing: Annealing

Data Source

PatentUS12473588B2Chemical and thermal assisted nucleic acid amplification methods
Publication Date: 2025.11.18 SINGULAR GENOMICS SYSTEMS INC
  • US12473588B2 patent drawing
  • US12473588B2 patent drawing
  • US12473588B2 patent drawing

AI summary

Disclosed herein, inter alia, are novel methods pertaining to nucleic acid amplification and detection. Devices, compositions, and kits for use in such methods are also provided.